Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Prescription Drugs

SyrSpend SF Suspending Base Recalled for Microbial Contamination

Agency Publication Date: May 9, 2022
Share:
Sign in to monitor this recall

Summary

Fagron, Inc. has recalled SyrSpend SF Suspending Base (Cherry Flavored), including a) 559 bottles and b) 243 bottles. The product is contaminated with Burkholderia gladioli, a type of bacteria. This suspending base is used by pharmacies and compounding centers to create liquid versions of medications. No incidents or injuries have been reported to date. Consumers who may have received a compounded medication using this base should contact their healthcare provider.

Risk

The product is contaminated with Burkholderia gladioli, which can cause serious respiratory or systemic infections, especially in individuals with compromised immune systems or underlying health conditions.

What You Should Do

  1. This recall affects SyrSpend SF Suspending Base (Cherry Flavored) packaged in 500mL bottles (NDC 51552-1123-5) and 4L bottles (NDC 51552-1123-9).
  2. Check the product label for lot numbers A67185 or A67186, both with an expiration date of 08/31/2024.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Fagron, Inc. for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: SyrSpend SF Suspending Base, Cherry Flavored (500mL)
Variants: Cherry Flavored, 500mL
Lot Numbers:
A67185 (Exp. Date 08/31/2024)
NDC:
51552-1123-5

Rx Only; Manufactured for Fagron, Inc.

Product: SyrSpend SF Suspending Base, Cherry Flavored (4L)
Variants: Cherry Flavored, 4L
Lot Numbers:
A67186 (Exp. Date 08/31/2024)
NDC:
51552-1123-9

Rx Only; Manufactured for Fagron, Inc.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 89805
Status: Resolved
Manufacturer: Fagron, Inc
Sold By: Pharmacies; Compounding Centers
Manufactured In: United States
Units Affected: a) 559 bottles and b) 243 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.